Jump to content

James W. Carroll

From Wikipedia, the free encyclopedia
Jim Carroll
Director of the Office of National Drug Control Policy
In office
February 9, 2018 – January 20, 2021
Acting: February 9, 2018 – January 3, 2019
PresidentDonald Trump
Preceded byRich Baum (Acting)
Succeeded byRegina LaBelle (Acting)
White House Principal Deputy Chief of Staff
In office
December 6, 2017 – February 9, 2018
PresidentDonald Trump
Preceded byKirstjen Nielsen
Succeeded byZachary Fuentes
Personal details
Political partyRepublican
EducationUniversity of Virginia (BA)
George Mason University (JD)

James W. Carroll Jr. is an American attorney and government appointee, who served as director of the Office of National Drug Control Policy in the Trump Administration from February 9, 2018 until January 20, 2021.[1][2]

Education

[edit]

Carroll received his B.A. from the University of Virginia and his J.D. degree from George Mason University.[3]

Career

[edit]

General Counsel in the Office of Management and Budget, and an attorney in the Office of the White House Counsel for Presidents Donald Trump and George W. Bush.[4] He later served as the White House Deputy Chief of Staff.[5]

Photo of Carroll

He was confirmed by the U.S. Senate as Office of National Drug Control Policy on January 2, 2019. Carroll was sworn into office by Vice President Mike Pence on January 31.[6]

In 2021, Carroll compared fentanyl to weapons of mass destruction.[7]

References

[edit]
  1. ^ "President Donald J. Trump Announces Appointments for the Executive Office of the President". whitehouse.gov. Retrieved February 9, 2018 – via National Archives.
  2. ^ "PN1864 — James W. Carroll Jr. — Executive Office of the President". U.S. Congress. Retrieved April 26, 2018.
  3. ^ "Jim Carroll – The White House". trumpwhitehouse.archives.gov. Retrieved 2023-07-08.
  4. ^ "President Donald J. Trump Announces Key Additions to the Office of the White House Counsel". whitehouse.gov. Retrieved March 7, 2017 – via National Archives.
  5. ^ Restuccia, Andrew; Karni, Annie (December 21, 2017). "Trump eyes former aides as West Wing staffers depart". Politico.
  6. ^ "APhA Attends Swearing-In Ceremony of National Drug Control Policy Director". American Pharmacists Association. February 4, 2019. Archived from the original on September 8, 2020. Retrieved March 16, 2019.
  7. ^ Vazquez, Maegan (2021-09-30). "Biden administration grapples with American addiction as overdose deaths hit a record high | CNN Politics". CNN. Retrieved 2023-07-08.
[edit]
Political offices
Preceded by
Rich Baum
Acting
Director of the Office of National Drug Control Policy
2018–2021
Acting: 2018–2019
Succeeded by
Regina LaBelle
Acting